Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma.

被引：0
|
作者：
Herrmann, E.
Marschner, N.
Grimm, M.
Ohlmann, C. H.
Hutzschenreuther, U.
Overkamp, F.
Groschek, M.
Blumenstengel, K.
Steiner, T.
机构：
[1] Univ Munster, Dept Urol, D-48149 Munster, Germany
[2] Univ Dresden, Dept Urol, Dresden, Germany
[3] Univ Saarland, Homburg, Germany
[4] Helios Hosp, Dept Urol, Erfurt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15061
引用
收藏
页数：1
相关论文
共 50 条
  • [11] SEQUENTIAL TARGET THERAPY FOR METASTATIC RENAL CELL CARCINOMA: COMPARISON OF SUNITINIB+SORAFENIB VS. SORAFENIB+SUNITINIB
    Antonelli, Alessandro
    Daja, Julian
    Ferrari, Vittorio
    Arrighi, Nicola
    Cunico, Sergio Cosciani
    Simeone, Claudio
    [J]. ANTICANCER RESEARCH, 2011, 31 (05) : 1922 - 1923
  • [12] Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma EDITORIAL COMMENT
    Tagawa, Scott T.
    [J]. JOURNAL OF UROLOGY, 2009, 182 (01): : 34 - 34
  • [13] Re: Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma Reply
    不详
    [J]. JOURNAL OF UROLOGY, 2010, 183 (02): : 825 - 825
  • [14] SEQUENTIAL THERAPY WITH SUNITINIB-SORAFENIB IN METASTATIC RENAL CELL CARCINOMA (MRCC): PRELIMINARY RESULTS
    Condorelli, Rosaria
    Buscarino, Calogero
    Ferrau, Francesco
    Novello, Giuseppe
    Vigneri, Paolo
    Restuccia, Nunzio
    Banna, Giuseppe Luigi
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [15] Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma
    Tomas Buchler
    Tomas Pavlik
    Zbynek Bortlicek
    Alexandr Poprach
    Rostislav Vyzula
    Jitka Abrahamova
    Bohuslav Melichar
    [J]. Medical Oncology, 2012, 29 : 3321 - 3324
  • [16] Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma
    Buchler, Tomas
    Pavlik, Tomas
    Bortlicek, Zbynek
    Poprach, Alexandr
    Vyzula, Rostislav
    Abrahamova, Jitka
    Melichar, Bohuslav
    [J]. MEDICAL ONCOLOGY, 2012, 29 (05) : 3321 - 3324
  • [17] Sunitinib in advanced metastatic renal cell carcinoma
    Gonzalez, Diana
    Casado, Gema
    Sierra, Ana
    Tacoronte, Angeles M.
    Herrero, Alicia
    Zamora, Pilar
    Jimenez, Esperanza
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 674 - 674
  • [18] Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency
    Khan, G.
    Golshayan, A.
    Elson, P.
    Wood, L.
    Garcia, J.
    Bukowski, R.
    Rini, B.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (08) : 1618 - 1622
  • [19] Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma
    Hiles, Jon J.
    Kolesar, Jill M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (02) : 123 - 131
  • [20] RETROSPECTIVE ANALYSIS OF THE SEQUENTIAL USE OF SORAFENIB AND SUNITINIB IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC)
    Porta, C.
    Procopio, G.
    Sabbatini, R.
    Bearz, A.
    Chiappino, I
    Imarisio, I.
    Guadalupi, V
    Paglino, C.
    Verzoni, E.
    Ferraris, E.
    Bajetta, E.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 183 - 183
12345